Dare Bioscience

Dare Bioscience PP&E per Employee

The PP&E per Employee of Dare Bioscience (DARE) as of Oct 30, 2026 is 11,557.81 USD. In the previous year, PP&E per Employee was 13,213.33 USD — a change of -12.53% (lower).

PP&E per Employee

11,557.81USD

YoY

-12.53%

Last updated:

PP&E per Employee of Dare Bioscience is 2021 11,557.81 USD. PP&E per Employee of Dare Bioscience was 2020 13,213.33 USD. It decreases by -12.53% lower compared to the previous year.

The Dare Bioscience PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2014
16,285.71 USD
Jan 1, 2015
27,428.57 USD
Jan 1, 2016
31,809.52 USD
Jan 1, 2018
447.43 USD
Jan 1, 2019
3,025.29 USD
Jan 1, 2020
13,213.33 USD
Jan 1, 2021
11,557.81 USD
The Dare Bioscience PP&E per Employee history
YEARPP&E per EmployeeYoY
11,557.81USD-12.53%
13,213.33USD+336.76%
3,025.29USD+576.15%
447.43USD-98.59%
31,809.52USD+15.97%
27,428.57USD+68.42%
16,285.71USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dare Bioscience Stock analysis

What does Dare Bioscience do? Daré Bioscience, Inc. develops and commercializes pharmaceutical products in women's reproductive health, focusing on non-hormonal contraceptive solutions. Its lead product, Ovaprene, is a clinical stage intravaginal ring designed to provide multi-week protection without intervention during intercourse. The ring features a permeable mesh barrier and localized spermiostatic agent delivery, combining barrier and spermicidal mechanisms to achieve efficacy comparable to diaphragms and short-acting hormonal methods like oral pills and vaginal rings. The company targets women seeking non-hormonal contraceptive options, with Ovaprene positioned as an alternative to existing hormonal products and barrier methods. The firm generates revenue through the development and commercialization of Ovaprene, aiming to address unmet needs in women's reproductive health. Ovaprene is designed to offer a non-hormonal, user-friendly alternative to traditional hormonal contraceptives, appealing to consumers who prefer avoiding hormonal side effects. The company's focus on clinical development and product commercialization aligns with the market demand for innovative, non-hormonal contraceptive options in women's health. Dare Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dare Bioscience stock

PP&E per Employee of Dare Bioscience is 11,557.81 USD in 2021.

PP&E per Employee of Dare Bioscience changed from 13,213.33 USD to 11,557.81 USD, representing a -12.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Dare Bioscience since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Dare Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Dare Bioscience

All Key Metrics — Dare Bioscience